文献速递主动脉疾病

开窗/分支腔内与开放胸腹主动脉瘤修复的医疗费用比较

Health care costs of endovascular compared with open thoracoabdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2020-10-21

基于加拿大安大略省行政健康数据库,纳入2006年1月至2017年2月664例胸腹主动脉瘤修复(开放361例,腔内303例),比较术后1年医疗费用。倾向性评分匹配后,腔内修复术后1个月中位费用显著高于开放修复(C$62,802 vs C$33,605,P<.01),1至12个月各阶段费用无显著差异。

要点

  • 腔内胸腹主动脉瘤修复术后1个月费用高于开放修复,主要因支架及辅助装置 upfront 成本。
  • 匹配后1至3个月、3至6个月、6至12个月费用两组无显著差异。
  • 开放修复相对腔内修复与术后1个月费用降低独立相关(RC 0.65,95%CI 0.56-0.74)。

核心结论

  • 胸腹主动脉瘤修复无论术式均费用高昂,腔内修复早期费用更高,但1至12个月费用无差异。

研究设计与样本

  • 基于安大略省行政健康数据库的人群回顾性队列,纳入2006年1月至2017年2月664例胸腹主动脉瘤修复(开放361例,腔内303例),采用倾向性评分匹配及多变量分析。

主要发现

  • 匹配前1个月中位费用腔内C$64,892 vs 开放C$36,647(P<.01),匹配后241对中腔内C$62,802 vs 开放C$33,605(P<.01)。
  • 匹配前1至3个月中位费用腔内C$2781 vs 开放C$2618(P=.71),匹配后C$2762 vs C$2092(P=.58)。
  • 3至6个月及6至12个月两组中位费用无显著差异。
  • 多变量分析中,年龄每增加5岁(RC 1.05,95%CI 1.04-1.06,P=.01)、急诊手术(RC 1.29,95%CI 1.10-1.52,P<.01)、卒中史(RC 1.34,95%CI 1.00-1.78,P=.05)与术后1个月费用增高相关;开放修复相对腔内修复与费用降低相关(RC 0.65,95%CI 0.56-0.74,P<.01)。

关键数值与推荐

  • 腔内修复索引手术的主动脉内移植物及辅助装置成本估计为每例C$44,000,开放手术为C$1,000(基于既往报告)。
  • 费用以2017年加元计算,分1个月、1至3个月、3至6个月、6至12个月四个阶段,并对死亡进行删失。

临床怎么用

  • 临床决策需考虑腔内胸腹主动脉瘤修复的早期高费用,尤其关注移植物成本。
  • 对于高龄、急诊手术或有卒中史患者,术后早期费用可能更高,应优化资源分配。
  • 若腔内装置成本下降,可能使两种术式总费用相当。

局限性

  • 研究为基于行政数据库的回顾性分析,可能受编码准确性影响。
  • 装置成本基于既往报告估算,而非直接测量。
  • 仅纳入加拿大安大略省单 payer 体系,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare 1-year health care costs between endovascular and open thoracoabdominal aortic aneurysm (TAAA). METHODS: Population-based administrative health databases were used to capture TAAA repairs performed in Ontario, Canada, between January 2006 and February 2017. All health care costs incurred by the Ministry of Health from a single-payer universal health care system were included. Costs of the aortic endografts and ancillary devices for the index procedure were estimated as C$44,000 per endovascular case vs C$1000 for open cases, based on previous reports. Costs (2017 Canadian dollars) were calculated in phases (1, 1-3, 3-6, and 6-12 months from surgery) with censoring for death. For each phase, propensity score matching of endovascular and open cases based on preoperative patient and hospital characteristics was used. The association between preoperative characteristics (including repair approach) and the first month postprocedure cost was characterized through multivariable analysis. RESULTS: Overall 664 TAAA repairs were identified (open, n = 361 [54.5%] and endovascular, n = 303 [45.6%]). At 1 month, the median cost was higher for endovascular TAAA repair in the prematching cohort (C$64,892 vs C$36,647; P < .01). Similarly, in 241 well-balanced endovascular/open patient pairs after propensity score matching, the median health care costs were higher in endovascular TAAA cases during the first month (C$62,802 vs C$33,605; P < .01). The 1- to 3-month median cost was not statistically different between endovascular and open TAAA cases either before matching (C$2781 vs C$2618; P = .71) or after matching (C$2762 vs C$2092; P = .58). Likewise, in the 3- to 6-month and 6- to 12-month postprocedure intervals, there were no significant differences in the median health care costs between groups. On multivariable analysis, older age (5-year increments) (relative change [RC] in mean cost, 1.05; 95% confidence interval [CI], 1.04-1.06; P = .01), urgent procedures (RC, 1.29; 95% CI, 1.10-1.52; P < .01), and history of stroke (RC, 1.34; 95% CI, 1.00-1.78; P = .05) were associated with higher costs in the first postoperative month, whereas open relative to endovascular TAAA repair was associated with a decreased 1-month cost (RC, 0.65; 95% CI, 0.56-0.74; P < .01). CONCLUSIONS: TAAA repair is expensive regardless of technique. Compared with open TAAA repair, endovascular repair was associated with a higher early cost, owing to the upfront cost of the endograft and aortic ancillary devices. There was no difference in cost from 1 to 12 months after repair. A decrease in the cost of endovascular devices might allow equivalent costs between endovascular and open TAAA repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rocha RV, De Mestral C, Tam DY, et al. Health care costs of endovascular compared with open thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2020. PMID: 33098943. doi:10.1016/j.jvs.2020.09.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。